Compounded Semaglutide

Why Semaglutide Can Make You Tired – and What Usually Helps

You expected appetite to change. You did not expect to feel flattened by 3pm. Here is what is usually behind it.

6 min read·Sources: FDA prescribing information, peer-reviewed trials and NIH literature·Updated August 2026·Educational content, not medical advice
The short answer

Fatigue on semaglutide is common in the early weeks and is usually driven by eating far less than before: fewer calories, less fluid, and lower electrolyte and iron intake. It typically improves when intake is rebuilt deliberately. Persistent or severe fatigue deserves a clinician review, not patience.

See your price Takes about 10 minutes · a clinician can decline · full refund if not prescribed
A person sitting on the edge of a bed in warm afternoon light

The most common cause is the most boring one

When appetite drops sharply, intake often drops faster than anyone intends. Under-eating produces exactly what patients describe: heavy legs, an afternoon wall, thinking through fog. It is not the molecule sedating you – it is a calorie and fluid deficit arriving faster than your body adapts.

Dehydration hides inside appetite loss

Much of daily fluid comes from food, and people rarely notice its absence. Add reduced thirst and it compounds. Dry mouth, headache, dizziness on standing and constipation usually point here first.

What your clinician may want to rule out

Low iron or B12, thyroid changes, sleep apnea, and blood-sugar swings all cause the same fatigue and all predate the medication in many patients. This is why a clinician may order labs rather than assume the medicine is the answer.

Semaglutide acts on the GLP-1 receptor – the same signalling your gut uses after a meal.

FDA prescribing information, semaglutide ↗

What usually helps

Protein at every meal even when you are not hungry. Fluid on a schedule, not on thirst. Salt unless you have been told to restrict it. Sleep protected like an appointment. Movement that is gentle – a walk beats nothing, and nothing is what fatigue argues for.

When to stop guessing and call

Fatigue with chest pain, breathlessness, fainting, persistent vomiting, severe abdominal pain, or an inability to keep fluids down is not a lifestyle problem. Contact your clinician promptly. See the 30-second film answers for this medication.

Why progress slows, and what a clinician looks at

Weight change is rarely linear, and a slowdown is the expected shape rather than a failure of the medication. Physiologically, energy requirements fall as body mass falls, so the same intake that once produced a deficit eventually does not. Appetite signalling also adapts. When someone reports a stall, a clinician generally reviews dose and where you are in the titration schedule, protein intake and resistance training as they relate to lean mass, sleep, alcohol, and other medications that affect weight independently. Some of those are adjustable and some are not. What a clinician will not do is promise that a dose increase resolves it. If lean mass is the concern, protecting muscle during treatment goes into what the evidence does and does not support.

FDA has warned about dosing errors reported with compounded GLP-1 products.

FDA drug safety communication ↗

How semaglutide works on the GLP-1 receptor

Semaglutide is a GLP-1 receptor agonist. GLP-1 is an incretin hormone your intestine releases after eating; it prompts insulin release when glucose is elevated, slows gastric emptying, and signals satiety in the hypothalamus. Semaglutide binds the same receptor, and structural modifications give it a long half-life, which is what makes once-weekly dosing possible for the injectable form. It acts on one receptor rather than two, which is the pharmacological difference from tirzepatide. According to the FDA prescribing information for semaglutide products, that mechanism is the basis of the approved indications. Oral semaglutide reaches the same receptor by a different route and carries strict dosing conditions as a result, which oral versus injectable semaglutide covers. Whether any form suits you is decided by a licensed clinician after an evaluation.

What compounded means, and what it does not

A compounded preparation is made by a licensed pharmacy for an individual patient on receipt of a valid prescription. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before they are marketed. That is a statement about regulatory pathway, not an accusation about any particular pharmacy, and it is why the distinction matters more than marketing language does. A compounded preparation is not a generic and not an equivalent of any FDA-approved brand product. Published clinical trials such as STEP-1 studied the branded product at studied doses; those findings should not be assumed to transfer. What compounded means unpacks the legal framework, and red flags when buying online covers how to tell a legitimate pharmacy from a grey-market seller.

Why side effects are mostly digestive, and mostly early

Because the receptors semaglutide acts on sit in the gut and the brainstem, the predictable effects are digestive: nausea, reflux, constipation, diarrhoea, and a feeling of fullness that arrives sooner than expected. According to FDA prescribing information for semaglutide products, gastrointestinal reactions are the most commonly reported adverse events, and they are dose-related for many people. The practical implication is that they tend to cluster around a dose change rather than persist indefinitely. Serious risks are listed separately in the label, including pancreatitis, gallbladder disease, and a boxed warning for thyroid C-cell tumours in rodents. Those are not common, but they are the reason the medication is prescription-only. Report severe or persistent abdominal pain, vomiting that stops you keeping fluids down, or vision changes to your clinician promptly rather than waiting for a scheduled check-in.

What if the answer is yes?

Ten minutes now, and a licensed clinician tells you where you actually stand.

Start your visitTakes about 10 minutes · a clinician can decline · full refund if not prescribed

Frequently asked questions

Does the tiredness go away?

For most people it eases within the first several weeks as intake stabilises. If it persists, worsens, or arrives with other symptoms, tell your clinician instead of waiting it out.

Should I lower my dose?

Never change a dose on your own. Report what you are feeling; adjusting the plan is a clinical decision.

How do I inject semaglutide?

Follow the instructions supplied with your specific preparation. Weekly peptide injections are generally subcutaneous, into the abdomen away from the navel, the outer thigh, or the back of the upper arm, rotating the site each week. Contact the pharmacy before injecting if anything about your dose or volume is unclear.

Where do you inject semaglutide?

Subcutaneous sites are the abdomen, outer thigh, and back of the upper arm. Rotating between them reduces local irritation. Your dispensing pharmacy provides site guidance for your preparation.

How long do semaglutide side effects last?

Gastrointestinal effects are dose-related for many people, so they commonly cluster around a dose change and settle as the body adapts. Persistent or severe symptoms are a reason to contact your clinician rather than wait.

Is Wegovy the same as Ozempic?

Both contain semaglutide, but they are separate FDA-approved products with different approved indications and dosing. Neither is the same as a compounded semaglutide preparation, which is not FDA-approved.

You should not have to white-knuckle your afternoons

Tell a licensed clinician what you are actually feeling and let the plan change. Rx only, refunded in full if you are not prescribed.

Takes about 10 minutes · a clinician can decline · full refund if not prescribed

Rx only. A licensed clinician decides whether treatment is appropriate and may determine that no treatment, or a different treatment, is right for you. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Individual results vary.

Sources

Clinical trials listed below evaluated FDA-approved products at the doses studied. They are cited as published science, not as evidence about any compounded preparation, which is not FDA-approved and has not been evaluated by FDA for safety, effectiveness, or quality.

  1. Peer-reviewedWilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021;384:989-1002
  2. NIHNIH Office of Dietary Supplements: Iron – Fact Sheet for Health Professionals
  3. FDA databaseDrugs@FDA: search approved labeling for semaglutide
  4. Peer-reviewedSTEP-1: Once-Weekly Semaglutide in Adults with Overweight or Obesity (NEJM 2021)

Spotted something inaccurate? Report an error – corrections are logged per our editorial standards.

More on Compounded Semaglutide

Same medication, different question.

See your price